Source: NewMediaWire

Acology Poised to Take Advantage of Federal CARERS Act

CORONA, CA--(Marketwired - Jun 7, 2016) - Acology Inc. (OTC PINK: ACOL) has published a position paper that outlines the company's unique position to take advantage of the passage of the Federal Government's CARERS Act later this year. (Knowledge Eclipse: Acology Looks Confidently Ahead to Repeal)

Having sold more than 600,000 units in the United States and Canada in the last 24 months Acology has positioned itself and its' signature product, The MedTainer™, as the categorically best and most compliant packaging, labeling and tracking container in the medical and recreational MJ Industry, fulfilling requirements for safe packaging in more than 30 States and every Canadian Province. Acology also asserts that it has successfully anticipated eventual US federal guidelines for safe, certified child-resistant medical and recreational MJ packaging. Acology and the MedTainer have created a distinctive, valuable niche in this fast-expanding market. This market includes all of North America, as the Canadian Federal Government has begun to look closely at safety-compliant packaging and The MedTainer is currently selling tens of thousands of units in that country.

The US is now considering The Compassionate Access, Research Expansion and Respect State Act (CARERS). This is by far the most comprehensive piece of federal medical marijuana legislation ever produced in Congress. This bi-partisan bill would finally remedy the state-federal conflicts over medical marijuana law with far-reaching effects. Among these would be the long-anticipated reduction of cannabis and CBDs from the current Schedule 1 Narcotic classification. Importantly, it will also create a banking mechanism for legal marijuana businesses to process deposits and profits. This in turn will open the door for the rapid expansion of businesses, like Acology Inc. that have established relationships with companies that are ready to take advantage of what will prove to be an immense financial opportunity.

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 201 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes", "estimate", "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

Acology Inc. and D&C Distributors are located in their new production and distribution facility at 1630 Commerce St. Corona, California, 92880. Acology trades on the OTC under the call letters ACOL. The company's emails are for the medical and recreational MJ industry and for the hospice and palliative care industry.

Contact Information:

Please send inquiries to

Acology Inc.
or call (844) ACOLOGY (844-226-5649) Ext. 3